FDA Inspection 1076386 — Astellas Pharma Inc.
The FDA completed an inspection of Astellas Pharma Inc. on December 13, 2018 in Takahagi. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 13, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Takahagi (Japan)